Zura Bio Issues Key Stakeholder Information Update
PremiumCompany AnnouncementsZura Bio Issues Key Stakeholder Information Update
2M ago
Zura Bio forms Scientific Advisory Board with leading experts
PremiumThe Fly
Zura Bio forms Scientific Advisory Board with leading experts
2M ago
Zura Bio Issues Key Press Statement to Investors
PremiumCompany Announcements
Zura Bio Issues Key Press Statement to Investors
2M ago
Zura Bio price target raised to $21 from $16 at Oppenheimer
PremiumThe FlyZura Bio price target raised to $21 from $16 at Oppenheimer
3M ago
Zura Bio reports Q1 EPS (2c), consensus (23c)
PremiumThe Fly
Zura Bio reports Q1 EPS (2c), consensus (23c)
3M ago
Amgen upgraded, Peloton downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Amgen upgraded, Peloton downgraded: Wall Street’s top analyst calls
3M ago
Zura Bio Issues Key Update for Investors
PremiumCompany AnnouncementsZura Bio Issues Key Update for Investors
4M ago
Zura Bio announces Robert Lisicki has assumed the role of CEO
PremiumThe Fly
Zura Bio announces Robert Lisicki has assumed the role of CEO
4M ago
Zura Bio price target lowered to $16 from $17 at Oppenheimer
PremiumThe Fly
Zura Bio price target lowered to $16 from $17 at Oppenheimer
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100